The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Abstract
Uterine leiomyomas develop during the reproductive years and regress after menopause, indicating ovarian steroid-dependent growth potential. Although the clinical and biochemical observations have traditionally supported an important role for estrogen in the promotion of leiomyoma growth, there is also increasing evidence to suggest the involvement of progesterone in the pathogenesis of leiomyoma. In this review, much attention has been paid to characterizing the molecular mechanisms of sex steroidal regulation of leiomyoma growth and apoptosis by evaluating the effects of sex steroids on the expression of growth factors and apoptosis-related factors. The effects of GnRH agonist on the expression of these factors in leiomyoma are also described. 17beta-Estradiol up-regulates epidermal growth factor (EGF) receptor, but down-regulates p53 protein in leiomyoma cells, whereas progesterone augments EGF and Bcl-2 protein, but inhibits insulin-like growth factor (IGF-I) and tumour necrosis factor (TNFalpha). Since it is now evident that EGF and IGF-I act as local factors which stimulate leiomyoma growth, these findings suggest that progesterone may have dual actions, stimulatory and inhibitory, on leiomyoma cell growth and survival, depending on the local growth factor conditions around each leiomyoma. This may explain why the size of uterine leiomyomas during the use of levonorgestrel-releasing intrauterine system (LNG-IUS) increases in some but decreases in other instances. This may also explain why the size of leiomyomas during pregnancy does not increase despite the overwhelming increase in circulating concentrations of sex steroid hormones. Moreover, there is further evidence to suggest that the interactions between estrogen receptors and progesterone receptors may be involved in the modulation of gene transcription activity in leiomyoma. This review demonstrates that leiomyoma growth is integrally regulated by the complex cross-talk between sex steroid hormones and growth factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“…or Bax, which are involved in the control of cell cycle (Kastan et al., 1992) and programmed cell death (Oltvai et al., 1993; Miyashita et al., 1994; Miyashita and Reed, 1995). p53 binds to damaged DNA, repairs it, and induces cell cycle arrest at G 1 -phase or apoptosis (Lee and Berstein, 1993).”
BackgroundGerm Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 4×
“Since p53 is a tumour suppressor gene that directly regulates the growth of tumours by inhibiting tumour cell growth or promoting cell death (Kastan et al., 1992; Oltvai et al., 1993; Miyashita et al., 1994, 1995), E 2 may stimulate leiomyoma growth in part by decreasing the p53 protein levels and…”
BackgroundInfluentialMutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
The biology of platelet-derived growth factor
Ross, R., Raines, E. W., & Bowen-Pope, D. F. (1986) · Cell · doi:10.1016/0092-8674(86)90733-6 · Cited by 2,008
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.625 · Cited by 1,697
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Overexpression of bcl-2 in transgenic models leads to accumulation of cells due to evasion of normal cell death mechanisms (McDonnell et al., 1989).”
BackgroundBcl-2 initiates a new category of oncogenes: regulators of cell death
Korsmeyer, S. (1992) · Blood · doi:10.1182/blood.v80.4.879.879 · Cited by 1,122
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Cell Surface Trafficking of Fas: A Rapid Mechanism of p53-Mediated Apoptosis
Bennett, M., Macdonald, K., Chan, S.-W., Luzio, J. P., Simari, R., & Weissberg, P. (1998) · Science · doi:10.1126/science.282.5387.290 · Cited by 754
Identification of a p53-dependent negative response element in the bcl-2 gene.
Miyashita, T., Harigai, M., Hanada, M., & Reed, J. C. (1994) · PubMed · Cited by 743
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.
Ignotz, R. A., Endo, T., & Massagué, J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48258-0 · Cited by 727
Párrizas, M., Saltiel, A. R., & LeRoith, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.154 · Cited by 653
p53 mutations increase resistance to ionizing radiation.
Lee, J. M., & Bernstein, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5742 · Cited by 564
Genetic Mechanisms of Tumor Suppression by the Human p53 Gene
Chen, P.-L., Chen, Y., Bookstein, R., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2274789 · Cited by 518
Gray, A., Dull, T. J., & Ullrich, A. (1983) · Nature · doi:10.1038/303722a0 · Cited by 510
Scott, J., Urdea, M., Quiroga, M., Sanchez-Pescador, R., Fong, N., Selby, M., Rutter, W. J., & Bell, G. I. (1983) · Science · doi:10.1126/science.6602382 · Cited by 443
The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P. W., & Baserga, R. (1995) · PubMed · Cited by 385
Oestrogen receptors – an overview
Enmark, E., & Gustafsson, J. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00545.x · Cited by 380
Nelson, K. G., Takahashi, T., Bossert, N. L., Walmer, D. K., & McLachlan, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.21 · Cited by 379
Uterine fibroids: A clinical review
VOLLENHOVEN, B. J., LAWRENCE, A. S., & HEALY, D. L. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb01804.x · Cited by 360
Wen, D. X., Xu, Y. F., Mais, D. E., Goldman, M. E., & McDonnell, D. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8356 · Cited by 355
Estrogen Induces Insulin—Like Growth Factor—I Expression in the Rat Uterus
Murphy, L. J., Murphy, L. C., & Friesen, H. G. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-7-445 · Cited by 349
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., & Brodeur, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.139 · Cited by 339
Growth regulatory properties of endothelins
Battistini, B., Chailler, P., D'Orléans-Juste, P., Brière, N., & Sirois, P. (1993) · Peptides · doi:10.1016/0196-9781(93)90057-n · Cited by 334
MURPHY, L. J., & GHAHARY, A. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-3-443 · Cited by 305
Estrogen Regulates the Synthesis of Epidermal Growth Factor in Mouse Uterine Epithelial Cells
Huet-Hudson, Y. M., Chakraborty, C., De, S. K., Suzuki, Y., Andrews, G. K., & Dey, S. K. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-3-510 · Cited by 278
The molecular action of tumor necrosis factor‐α
CAMUSSI, G., ALBANO, E., TETTA, C., & BUSSOLINO, F. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16337.x · Cited by 271
BCL‐2 expression in adult and embryonic non‐haematopoietic tissues
Lu, Q., Poulsom, R., Wong, L., & Hanby, A. M. (1993) · The Journal of Pathology · doi:10.1002/path.1711690408 · Cited by 261
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., & Yen, S. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432797 · Cited by 247
Mitotic activity in uterine leiomyomas during the menstrual cycle
Kawaguchi, K., Fujii, S., Konishi, I., Nanbu, Y., Nonogaki, H., & Mori, T. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(89)80046-8 · Cited by 240
Growth hormone: roles in female reproduction
Hull, K., & Harvey, S. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1680001 · Cited by 234
Cancer. p53 Guardian of the Genome
Rokudai, S. (2017) · The KITAKANTO Medical Journal · doi:10.2974/kmj.67.63 · Cited by 232
Arici, A., & Sozen, I. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00418-0 · Cited by 225
Parrizas, M. (1997) · Endocrinology · doi:10.1210/en.138.3.1355 · Cited by 219
Brandon, D. D., Bethea, C. L., Strawn, E. Y., Novy, M. J., Burry, K. A., Harrington, M. S., Erickson, T. E., Warner, C., Keenan, E. J., & Clinton, G. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90135-6 · Cited by 207
p53: the ultimate tumor suppressor gene?
Oren, M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.13.1397838 · Cited by 206
Friedman, A. J., Barbieri, R. L., Doubilet, P. M., Fine, C., & Schiff, I. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59763-5 · Cited by 198
KATZENELLENBOGEN, B. S., & JANE NORMAN, M. (1990) · Endocrinology · doi:10.1210/endo-126-2-891 · Cited by 185
Kraus, W. L., Weis, K. E., & Katzenellenbogen, B. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1847 · Cited by 185
Carr, B. R. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1217 · Cited by 184
IGF binding proteins and their functions
Clemmons, D. R. (1993) · Molecular Reproduction and Development · doi:10.1002/mrd.1080350409 · Cited by 176
Bulun, S. E., Simpson, E. R., & Word, R. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126151 · Cited by 172
Matthews, C. C., & Feldman, E. L. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199602)166:2<323::aid-jcp10>3.0.co;2-c · Cited by 168
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect
Murphy, A. A., Morales, A. J., Michael Kettel, L., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57678-x · Cited by 164
Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus
Nelson, K. G. (1992) · Endocrinology · doi:10.1210/en.131.4.1657 · Cited by 161
Das, S. K., Flanders, K. C., Andrews, G. K., & Dey, S. K. (1992) · Endocrinology · doi:10.1210/endo.130.6.1375903 · Cited by 160
Matsuo, H., Maruo, T., & Samoto, T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3650 · Cited by 159
Self-citationNisolle, M., Gillerot, S., Casanas-Roux, F., Squifflet, J., Berliere, M., & Donnez, J. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2844 · Cited by 159
Stewart, E. A., Friedman, A. J., Peck, K., & Nowak, R. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077380 · Cited by 157
Regression of uterine leiomyomata in response to the antiprogesterone RU 486
Murphy, A. A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.513 · Cited by 153
Shimomura, Y., Matsuo, H., Samoto, T., & Maruo, T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4879 · Cited by 151
Self-citationSpecifying the cellular responses to IGF signals: roles of IGF-binding proteins
Duan, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750041 · Cited by 149
Effects of progesterone on uterine leiomyoma growth and apoptosis
Maruo, T. (2000) · Steroids · doi:10.1016/s0039-128x(00)00171-9 · Cited by 144
Self-citationGhahary, A., & Murphy, L. J. (1989) · Endocrinology · doi:10.1210/endo-125-2-597 · Cited by 140
Lee, B. S., & Nowak, R. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7237 · Cited by 137
Defining the actions of transforming growth factor beta in reproduction
Ingman, W. V., & Robertson, S. A. (2002) · BioEssays · doi:10.1002/bies.10155 · Cited by 136
The Effect of Progestins on the Mitotic Activity of Uterine Fibromyomas
Tiltman, A. J. (1985) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198506000-00001 · Cited by 134
Giudice, L. C., Irwin, J. C., Dsupin, B. A., Pannier, E., Jin, I. H., Vu, T. H., & Hoffman, A. R. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137937 · Cited by 131
Pollard, J. W. (1990) · Reproduction · doi:10.1530/jrf.0.0880721 · Cited by 123
Suppression of Interleukin-1β-converting Enzyme-mediated Cell Death by Insulin-like Growth Factor
Jung, Y., Miura, M., & Yuan, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5112 · Cited by 121
Binding Sites for Epidermal Growth Factor in Human Uterine Tissues and Leiomyomas
HOFMANN, G. E., Rao, C. V., Barrows, G. H., et al. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-5-880 · Cited by 120
Rossi, M. J., Chegini, N., & Masterson, B. J. (1992) · Endocrinology · doi:10.1210/en.130.3.1716 · Cited by 118
Insulin-Like Growth Factor I Modulates Induction of Apoptotic Signaling in H9C2 Cardiac Muscle Cells
Wang, L., Ma, W., Markovich, R. P., Lee, W.-L., & Wang, P. H. (1998) · Endocrinology · doi:10.1210/endo.139.3.5801 · Cited by 118
Chegini, N., Rong, H., Dou, Q., Kipersztok, S., & Williams, R. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784072 · Cited by 116
Tumor Necrosis Factor- in the Female Reproductive Tract
Terranova, P. F., Hunter, V., Roby, K. F., & Hunt, J. S. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-209-43905b · Cited by 113
Dou, Q., Zhao, Y., Tarnuzzer, R. W., Rong, H., Williams, R. S., Schultz, G. S., & Chegini, N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784073 · Cited by 108
Maruo, T., Laoag‐Fernandez, J. B., Pakarinen, P. I., Murakoshi, H., Spitz, I. M., & Johansson, E. D. B. (2001) · Human Reproduction · doi:10.1093/humrep/16.10.2103 · Cited by 108
Self-citationJung, M.-S., Yun, J., Chae, H., Kim, J., Kim, S., Choi, T.-S., & Shin, D. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204748 · Cited by 101
Matsuo, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.293 · Cited by 98
Hague, S. J., Zhang, L., Oehler, M. K., Manek, S., MacKenzie, I. Z., Bicknell, R., & REES, M. C. P. (2000) · PubMed · Cited by 97
Viville, B., Jones, D. S., Sharkey, A., Wetzka, B., & Smith, S. K. (1997) · Human Reproduction · doi:10.1093/humrep/12.4.815 · Cited by 96
Structural aspects of the IGFBP family.
Sl, D., Ag, S., Lindenbergh-Kortleve, D. J., Groffen, C., Brinkman, A., & Zwarthoff, E. C. (1992) · PubMed · Cited by 96
Kettel, L. M., Murphy, A. A., Morales, A. J., & Yen, S. S. C. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.116 · Cited by 95
Dixon, D., He, H., & Haseman, J. K. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s5795 · Cited by 92
Chegini, N., Ma, C., Tang, X. M., & Williams, R. S. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.12.1071 · Cited by 91
Graham, J. D., Roman, S. D., McGowan, E. M., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30693 · Cited by 90
Andersen, J., DyReyes, V. M., Barbieri, R. L., Coachman, D. M., & Miksicek, R. J. (1995) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(94)00053-4 · Cited by 90
Norstedt, G., Levinovitz, A., & Eriksson, H. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200466 · Cited by 88
Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium
GENTRY, C. C., Okolo, S., Fong, L. F. W. T., Crow, J. C., MacLean, A., & Perrett, C. W. (2001) · Clinical Science · doi:10.1042/cs1010691 · Cited by 84
Harrison‐Woolrych, M., Jones, D. S., & Smith, S. K. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175976 · Cited by 79
Uterine leiomyomata--aetiology, symptomatology and management.
Buttram, V. C. (1986) · PubMed · Cited by 79
Tumor Necrosis Factor- Expression in Human Uterine Leiomyoma and Its Down-Regulation by Progesterone
Kurachi, O., Matsuo, H., Samoto, T., & Maruo, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7469 · Cited by 78
Self-citationTommola, P., Pekonen, F., & Rutanen, E. ‐. (1989) · PubMed · Cited by 72
Insulin-like growth factor I promotes leiomyoma cell growth in vitro
Strawn, E., Novy, M. J., Burry, K. A., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91420-x · Cited by 69
Shozu, M., Sumitani, H., Segawa, T., Yang, H.-J., Murakami, K., Kasai, T., & Inoue, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8533 · Cited by 66
Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata
Wiznitzer, A., Marbach, M., Hazum, E., Inster, V., Sharoni, Y., & Levy, J. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80430-3 · Cited by 64
Gao, Z., Matsuo, H., Wang, Y., Nakago, S., & Maruo, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5593 · Cited by 64
Self-citationp53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus
Jeffers, M. D., Farquharson, M. A., Richmond, J. A., & McNicol, A. (1995) · The Journal of Pathology · doi:10.1002/path.1711770111 · Cited by 58
Arici, A. M., & Sozen, I. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.118 · Cited by 58
Mizutani, T., Sugihara, A., Nakamuro, K., & Terada, N. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1253 · Cited by 57
Chegini, N., Tang, X., & Ma, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6147 · Cited by 56
Expression of estrogen receptor α and β in myometrium of premenopausal and postmenopausal women
Sakaguchi, H., Fujimoto, J., Aoki, I., & Tamaya, T. (2002) · Steroids · doi:10.1016/s0039-128x(02)00111-3 · Cited by 49
der Ven, L. V., Roholl, P. J. M., Gloudemans, T., van Buul-Offers, S. C., Welters, M. J. P., Bladergroen, B. A., Faber, J. A. J., Sussenbach, J. S., & Otter, W. D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.278 · Cited by 49
Yamada, T. (2004) · Human Reproduction · doi:10.1093/humrep/deh146 · Cited by 49
Wang, Y., Matsuo, H., Kurachi, O., & Maruo, T. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460447 · Cited by 49
Self-citationAdesanya, O. O., Zhou, J., & Bondy, C. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626866 · Cited by 47
Inhibition of in Situ Expression of Aromatase P450 in Leiomyoma of the Uterus by Leuprorelin Acetate
Shozu, M., Sumitani, H., Segawa, T., Yang, H.-J., Murakami, K., & Inoue, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8026 · Cited by 46
Englund, K. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.10.915 · Cited by 43
Immunofluorescent Analysis of Estrogen Induction of Progesterone Receptor in the Rhesus Uterus*
Okulicz, W. C., Savasta, A. M., Hoberg, L. M., & Longcope, C. (1989) · Endocrinology · doi:10.1210/endo-125-2-930 · Cited by 40
Wu, X., Blanck, A., Olovsson, M. H., Möller, B., Favini, R., & Lindblom, B. (2000) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2000.079005397.x · Cited by 39
Expression of Progesterone Receptor Form A and B mRNAs in Uterine Leiomyoma
Fujimoto, J., Hirose, R., Ichigo, S., Sakaguchi, H., Li, Y., & Tamaya, T. (1998) · Tumor Biology · doi:10.1159/000029983 · Cited by 39
Nerve growth factor inhibits apoptosis induced by tumor necrosis factor in PC12 cells
Haviv, R., & Stein, R. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990201)55:3<269::aid-jnr1>3.0.co;2-3 · Cited by 38
Hodges-Gallagher, L., Houston, K. D., Hunter, D., Fuchs‐Young, R., Zhang, Z., Winneker, R. C., & Walker, C. L. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00230-7 · Cited by 32
Smooth muscle cell and endothelial cell growth factors
Klagsbrun, M., & Dluz, S. (1993) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(93)90042-5 · Cited by 31
Huang, S.-C., Tang, M., Hsu, K., Cheng, Y.-M., & Chou, C.-Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011968 · Cited by 27
Tumour necrosis factor-α modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro
Danforth, D. N., & Sgagias, M. K. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1380517 · Cited by 23
Wu, X., Wang, H., Englund, K., Blanck, A., Lindblom, B., & Sahlin, L. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03378-2 · Cited by 17
Lieto, A. D., Iannotti, F., Falco, M. D., Staibano, S., Pollio, F., Ciociola, F., & Rosa, G. D. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.180 · Cited by 9
Cited by
The Management of Uterine Leiomyomas
Vilos, G. A., Allaire, C., Laberge, P.-Y., Leyland, N., Vilos, A. G., Murji, A., & Chen, I. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30338-8 · Cited by 642
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma
Ishikawa, H., Ishi, K., Serna, V. A., Kakazu, R., Bulun, S. E., & Kurita, T. (2010) · Endocrinology · doi:10.1210/en.2009-1225 · Cited by 362
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics
Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M., & Ciarmela, P. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx032 · Cited by 321
Metadata
- Authors
- Maruo, T.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 10
- Issue
- 3
- Pages
- 207-220
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2110117792
- Cited by
- 294
- References
- 123
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.